Pages with the fewest revisions

Jump to: navigation, search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Specific Neonatal Case definitions‏‎ (1 revision)
  2. Graphs, charts, diagrams‏‎ (1 revision - redirect page)
  3. Health care settings‏‎ (1 revision)
  4. Writing for Publications‏‎ (1 revision - redirect page)
  5. Measurement in Field Epidemiology‏‎ (1 revision - redirect page)
  6. Public Health Interventions‏‎ (1 revision - redirect page)
  7. Causal Inference‏‎ (1 revision - redirect page)
  8. Data Capture Systems‏‎ (1 revision - redirect page)
  9. Surveillance and investigation of healthcare-associated infections‏‎ (1 revision - redirect page)
  10. Effect Modification and Confounding‏‎ (1 revision - redirect page)
  11. Expert Advice‏‎ (1 revision)
  12. To professionals‏‎ (1 revision - redirect page)
  13. HAI Surveillance at the EU level - importance of international networks‏‎ (1 revision - redirect page)
  14. Health communication‏‎ (1 revision - redirect page)
  15. Introduction to Public Health and basic concepts‏‎ (1 revision - redirect page)
  16. Methods in Field Epidemiology‏‎ (1 revision - redirect page)
  17. Outbreak Investigations‏‎ (1 revision - redirect page)
  18. Public Health Law‏‎ (1 revision - redirect page)
  19. Bone and Joint Infection‏‎ (1 revision)
  20. Refining the estimated point in time of an outbreak source‏‎ (1 revision - redirect page)
  21. Surveillance attributes for evaluation‏‎ (1 revision - redirect page)
  22. Eye, Ear, Nose or Mouth Infection‏‎ (1 revision)
  23. HAI case definitions for use in hospitals‏‎ (1 revision - redirect page)
  24. Investigations in Special Circumstances‏‎ (1 revision - redirect page)
  25. Measures of Disease Impact‏‎ (1 revision - redirect page)
  26. About‏‎ (1 revision)
  27. Presenting Data‏‎ (1 revision)
  28. Public Health Microbiology‏‎ (1 revision - redirect page)
  29. Confirm the outbreak‏‎ (1 revision - redirect page)
  30. Significance and Confidence‏‎ (1 revision - redirect page)
  31. Decision 1082/2013/EU: Serious cross border health threat‏‎ (1 revision - redirect page)
  32. Vaccination‏‎ (1 revision - redirect page)
  33. Measures of Disease Occurrence‏‎ (1 revision - redirect page)
  34. Presenting Statistics‏‎ (1 revision)
  35. Public Health Programs‏‎ (1 revision - redirect page)
  36. Burden of HAIs‏‎ (1 revision)
  37. Sampling‏‎ (1 revision - redirect page)
  38. Epidemic intelligence‏‎ (1 revision - redirect page)
  39. Types of Cluster‏‎ (1 revision)
  40. Hand hygiene‏‎ (1 revision - redirect page)
  41. Construction of Epidemic Curves‏‎ (1 revision - redirect page)
  42. Skin and Soft Tissue Infections‏‎ (1 revision)
  43. Surveillance of Clostridium difficile infections‏‎ (1 revision)
  44. Testing the Tests‏‎ (1 revision - redirect page)
  45. Field Epidemiology‏‎ (1 revision - redirect page)
  46. Types of HAIs‏‎ (1 revision - redirect page)
  47. Hand hygiene - principles‏‎ (1 revision - redirect page)
  48. Healthcare-associated infection prevention and control as a part of patient safety programme‏‎ (1 revision - redirect page)
  49. Reproductive Tract Infections‏‎ (1 revision)
  50. Choosing a Reference Group‏‎ (1 revision - redirect page)
  51. Surveillance of HAIs in intensive care units‏‎ (1 revision)
  52. Fitting logistic regression models‏‎ (1 revision - redirect page)
  53. Healthcare-associated infection prevention and control programme‏‎ (1 revision - redirect page)
  54. Models‏‎ (1 revision - redirect page)
  55. Prevention‏‎ (1 revision - redirect page)
  56. Applied Immunology‏‎ (1 revision - redirect page)
  57. Scientific (evidence base for prevention)‏‎ (1 revision - redirect page)
  58. Describe the outbreak‏‎ (1 revision - redirect page)
  59. Surveillance of healthcare-associated infections - definition‏‎ (1 revision - redirect page)
  60. Establishing a Surveillance System‏‎ (1 revision - redirect page)
  61. The European Surveillance System (TESSy)‏‎ (1 revision)
  62. Types of Outbreak‏‎ (1 revision - redirect page)
  63. Healthcare-associated infections and risk assessment‏‎ (1 revision - redirect page)
  64. Indicator-based Surveillance‏‎ (1 revision - redirect page)
  65. ECDC PPS in acute care hospitals‏‎ (1 revision - redirect page)
  66. Surveillance of healthcare-associated infections - other approaches‏‎ (1 revision - redirect page)
  67. Infection control and hospital hygiene‏‎ (1 revision - redirect page)
  68. Lobbying‏‎ (1 revision)
  69. Questionnaire Design‏‎ (1 revision - redirect page)
  70. Descriptive data analysis‏‎ (1 revision - redirect page)
  71. Statistical Concepts‏‎ (1 revision - redirect page)
  72. The Role of Microbiology‏‎ (1 revision - redirect page)
  73. Types of Questions‏‎ (1 revision - redirect page)
  74. Infection control interventions‏‎ (1 revision - redirect page)
  75. Logistic Regression‏‎ (1 revision - redirect page)
  76. Case-control studies‏‎ (1 revision - redirect page)
  77. Cluster Investigations‏‎ (1 revision - redirect page)
  78. Screening‏‎ (1 revision - redirect page)
  79. ECDC point prevalence survey of healthcare-associated infections and antimicrobial use in long term care facilities‏‎ (1 revision)
  80. Surveillance principles‏‎ (1 revision - redirect page)
  81. Types of Study‏‎ (1 revision - redirect page)
  82. Hand hygiene products selection and evaluation‏‎ (1 revision - redirect page)
  83. Hints to Design a Good Questionnaire‏‎ (1 revision - redirect page)
  84. Information (Measurement) Bias‏‎ (1 revision - redirect page)
  85. Lower Respiratory Tract Infection other than pneumonia‏‎ (1 revision)
  86. Analysing a public health problem‏‎ (1 revision - redirect page)
  87. Assessing the burden of disease and risk assessment‏‎ (1 revision - redirect page)
  88. Rapid Risk Assessment‏‎ (1 revision - redirect page)
  89. Case Definitions‏‎ (1 revision - redirect page)
  90. Statistical Tests‏‎ (1 revision - redirect page)
  91. ECDC surveillance of Surgical Site Infections‏‎ (1 revision)
  92. European surveillance of healthcare-associated infections‏‎ (1 revision - redirect page)
  93. Health Economics‏‎ (1 revision - redirect page)
  94. Informing Action / Improving Knowledge‏‎ (1 revision - redirect page)
  95. Main Page‏‎ (1 revision - redirect page)
  96. Non-traditional designs‏‎ (1 revision - redirect page)
  97. Privacy policy‏‎ (1 revision)
  98. Rash diseases in childhood‏‎ (1 revision - redirect page)
  99. Cohort studies‏‎ (1 revision - redirect page)
  100. Selection Bias‏‎ (1 revision - redirect page)
  101. Stratified Analysis‏‎ (1 revision - redirect page)
  102. Systemic Infections‏‎ (1 revision)
  103. Gastrointestinal System Infections‏‎ (1 revision)
  104. Main pathogens and resistance‏‎ (1 revision - redirect page)
  105. Rationale for Outbreak Investigations‏‎ (1 revision - redirect page)
  106. Case definitions for outbreak assessment‏‎ (1 revision - redirect page)
  107. Evaluation of Surveillance Systems‏‎ (1 revision - redirect page)
  108. General Communication‏‎ (1 revision - redirect page)
  109. Host‏‎ (1 revision - redirect page)
  110. International Health Regulations 2005 edition‏‎ (1 revision - redirect page)
  111. Odds‏‎ (1 revision - redirect page)
  112. Analysis by place characteristics‏‎ (1 revision - redirect page)
  113. Problems with Measurement‏‎ (1 revision - redirect page)
  114. Bias‏‎ (1 revision - redirect page)
  115. Case definitions of healthcare infections‏‎ (1 revision - redirect page)
  116. Root‏‎ (1 revision - redirect page)
  117. Selection bias and case-control studies‏‎ (1 revision - redirect page)
  118. Spatial Analysis (Geographical Information Systems)‏‎ (1 revision)
  119. Surgical Site Infection‏‎ (1 revision)
  120. EU Public Health Legislation‏‎ (1 revision - redirect page)
  121. The role of the clinical microbiology laboratory in infection prevention and control‏‎ (1 revision - redirect page)
  122. Urinary Tract Infection‏‎ (1 revision)
  123. Health Informatics Standards – general introduction‏‎ (1 revision - redirect page)
  124. Writing a Study Protocol‏‎ (1 revision - redirect page)
  125. Matching‏‎ (1 revision - redirect page)
  126. Possible Terrorist / Deliberate Event‏‎ (1 revision)
  127. Analysis by time characteristics‏‎ (1 revision - redirect page)
  128. How pathogens try to trick our defenses‏‎ (1 revision - redirect page)
  129. Opportunities and Challenges‏‎ (1 revision - redirect page)
  130. Power and Sample Size‏‎ (1 revision - redirect page)
  131. Analysis of Surveillance Data‏‎ (1 revision - redirect page)
  132. Public Health Informatics‏‎ (1 revision - redirect page)
  133. Bioinformatics‏‎ (1 revision)
  134. Rubella‏‎ (1 revision)
  135. Communication of findings‏‎ (1 revision - redirect page)
  136. Sensitivity Analysis‏‎ (2 revisions)
  137. Cross-sectional Studies‏‎ (2 revisions)
  138. Disasters and Emergencies‏‎ (2 revisions)
  139. Experimental Studies‏‎ (2 revisions)
  140. To Public and the Media‏‎ (2 revisions)
  141. Use of computers‏‎ (2 revisions)
  142. Hygiene and Sanitation‏‎ (2 revisions)
  143. Interviewer Bias‏‎ (2 revisions)
  144. Analytical Study Designs‏‎ (2 revisions)
  145. SMART definitions‏‎ (2 revisions)
  146. Tertiary prevention‏‎ (2 revisions)
  147. Writing for Stakeholders‏‎ (2 revisions)
  148. Measures of Accuracy in Screening‏‎ (2 revisions)
  149. Microbial flora of the hands‏‎ (2 revisions)
  150. Outbreak communication‏‎ (2 revisions)
  151. Antigen presenting cells (APC)‏‎ (2 revisions)
  152. Central Nervous System Infection‏‎ (2 revisions)
  153. Dose Effect‏‎ (2 revisions)
  154. Test Reproducibility‏‎ (2 revisions)
  155. Transmission routes‏‎ (2 revisions)
  156. HFMD‏‎ (2 revisions)
  157. Health literacy‏‎ (2 revisions)
  158. Antigens (Ag)‏‎ (2 revisions)
  159. Reporting Bias‏‎ (2 revisions)
  160. Validated questionnaires‏‎ (2 revisions)
  161. Incidence rate‏‎ (2 revisions)
  162. Measures of association‏‎ (2 revisions)
  163. Additional resources for presenting findings‏‎ (2 revisions)
  164. Public health response (informing control)‏‎ (2 revisions)
  165. Scarlatina‏‎ (2 revisions)
  166. ECDC PPS - inclusion/exclusion criteria‏‎ (2 revisions)
  167. Incubation period, Latent period and Generation time‏‎ (2 revisions)
  168. Laboratory Support‏‎ (2 revisions)
  169. Antimicrobial stewardship‏‎ (2 revisions)
  170. Skin care‏‎ (2 revisions)
  171. ECDC PPS in European acute care hospitals, definition of HAI‏‎ (2 revisions)
  172. Types of Microorganisms‏‎ (2 revisions)
  173. Indications for hand hygiene‏‎ (2 revisions)
  174. Line graphs‏‎ (2 revisions)
  175. Measures of effect in various study designs‏‎ (2 revisions)
  176. Capture-recapture‏‎ (2 revisions)
  177. ECDC PPS in European acute care hospitals protocol‏‎ (2 revisions)
  178. Molecular epidemiology‏‎ (2 revisions)
  179. Applying Epidemiology for the International Health Regulations.‏‎ (2 revisions)
  180. Cardiovascular System Infection‏‎ (2 revisions)
  181. Social marketing‏‎ (2 revisions)
  182. Descriptive Studies‏‎ (2 revisions)
  183. Standardization of rates‏‎ (2 revisions)
  184. Hand hygiene for patients and visitors‏‎ (2 revisions)
  185. Helminthic mechanisms of immune evasion‏‎ (2 revisions)
  186. Pilot testing‏‎ (2 revisions)
  187. Aesthetic preferences‏‎ (2 revisions)
  188. Response Bias‏‎ (2 revisions)
  189. European Antimicrobial Resistance Surveillance Network (EARS-Net)‏‎ (2 revisions)
  190. Hand hygiene methods‏‎ (2 revisions)
  191. Herd immunity‏‎ (2 revisions)
  192. Nails, rings, watches, bracelets‏‎ (2 revisions)
  193. Restriction‏‎ (2 revisions)
  194. Cooperative learning as active learning in adult‏‎ (2 revisions)
  195. Detection Bias‏‎ (2 revisions)
  196. European Surveillance of Antimicrobial Consumption Network (ESAC-Net)‏‎ (2 revisions)
  197. Frequency polygons‏‎ (2 revisions)
  198. Web-crawling Applications‏‎ (2 revisions)
  199. Measuring protection‏‎ (2 revisions)
  200. Non-response bias‏‎ (2 revisions)
  201. Cognitive bias‏‎ (2 revisions)
  202. Cost-effectiveness‏‎ (2 revisions)
  203. Source of infection‏‎ (2 revisions)
  204. Developing a control definition‏‎ (2 revisions)
  205. Survival bias‏‎ (2 revisions)
  206. The idea of Statistical Inference‏‎ (2 revisions)
  207. Types of Surveillance System (Active vs Passive)‏‎ (2 revisions)
  208. Cost-minimisation‏‎ (2 revisions)
  209. Sources and Types of Data‏‎ (2 revisions)
  210. Developing infection control interventions: isolation‏‎ (2 revisions)
  211. EU Food Safety Legislation‏‎ (2 revisions)
  212. What determines our susceptibility to infections?‏‎ (2 revisions)
  213. Probability‏‎ (2 revisions)
  214. Cohorting patients and/or staff‏‎ (2 revisions)
  215. Cost-utility‏‎ (2 revisions)
  216. Sources and Types of Surveillance Data‏‎ (2 revisions)
  217. Structure of an Outbreak Investigation Report‏‎ (2 revisions)
  218. EU Legislation for Communicable Diseases Surveillance‏‎ (2 revisions)
  219. The outbreak management team‏‎ (2 revisions)
  220. Unmasking Outbreak Source through Segmentation‏‎ (2 revisions)
  221. Mechanism of infectious disease‏‎ (2 revisions)
  222. Political Interests and Populism‏‎ (2 revisions)
  223. Recall Bias‏‎ (2 revisions)
  224. Evaluation of the microbicidal activities of hand-rub and hand-wash agents‏‎ (2 revisions)
  225. Glossary‏‎ (2 revisions)
  226. Interpreting Data‏‎ (2 revisions)
  227. Product accessibility and cost‏‎ (2 revisions)
  228. Case to case study design‏‎ (2 revisions)
  229. Roseola‏‎ (2 revisions)
  230. Education and training of staff‏‎ (2 revisions)
  231. Tables‏‎ (2 revisions)
  232. Gloves and hand hygiene‏‎ (2 revisions)
  233. Health advocacy‏‎ (2 revisions)
  234. Methods for assessing environmental cleanliness‏‎ (2 revisions)
  235. Bloodstream Infection‏‎ (3 revisions)
  236. Referral bias‏‎ (3 revisions)
  237. Sensitivity and Specificity of a case definition‏‎ (3 revisions)
  238. Stage 0: Preparation for rapid risk assessment‏‎ (3 revisions)
  239. Disentangling Complex Data‏‎ (3 revisions)
  240. Identifying Multiple Possible Outbreak Sources‏‎ (3 revisions)
  241. Antibodies‏‎ (3 revisions)
  242. SOCO (single over-riding communications objective)‏‎ (3 revisions)
  243. Confidence Intervals‏‎ (3 revisions)
  244. Seven Golden Rules to Design Questions‏‎ (3 revisions)
  245. Stage 1: Collecting event information‏‎ (3 revisions)
  246. Test Precision‏‎ (3 revisions)
  247. VAP‏‎ (3 revisions)
  248. Writing style of an Outbreak Investigation Report‏‎ (3 revisions)
  249. Brief history of International Communicable Disease Law‏‎ (3 revisions)
  250. Relation between risk and incidence rate‏‎ (3 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)